samedan logo
 
 
spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Clinical Trial Supply East coast 2018

16-17 October 2018
King of Prussia, PA

This unique event brings together leading pharma, device and biotech professionals from across the East Coast region, to collaboratively enhance the clinical supply chain. Over the two days, delegates and speakers will discuss how to select forecasting and planning technology, how to reduce waste in clinical trials supplies, how to choose your packaging strategy, but we will also discover all the new technologies that will disrupt your clinical trials supplies.

The event will be split into two streams, to explore the operational and technological challenges which many companies are facing today. Impressed? Then book your tickets now before they run out!

2018 Key Session:

  • Interactive session: Diving into innovations that will change your clinical trial supplies
  • Developing a Just-in-Time labeling strategy to save time and reduce costs
  • Panel Discussion: Cutting costs but minimizing waste in your supply chain
  • Capitalizing on opportunities and overcoming challenges in Direct-to-Patient clinical trial strategies
  • Electronic Labels (eLabels) in Clinical Supplies: Understanding the Benefits for Patients, Sites and Sponsors

2018 Speakers:

1.      Anthony Zuccarello, Associate Director, IRT and Global Clinical Supply Strategy, Amicus Therapeutics

2.      Linda Nichols, Strategic Value Manager, GDS Global, Supply Chain Management, GSK

3.      Natalie Weaver, Supply Chain Lead, Pfizer

4.      Augustin Pegan, R.Ph., Director, Clinical Supply & CMC Development, SK Life Science

5.      Johnny Yi Zhang, Senior Manager Clinical Supply Chain, Biogen

6.      Craig Mooney, Director IRT,Bristol-Myers Squibb

7.      Jeff Conover, Associate Director, Global Clinical Supplies, Novartis

Useful links:  

2018 Event Website: http://www.arena-international.com/ctseastcoast/ 

2018 Registration (Exclusive Partner Priority Code: MK-ACMP): http://www.spgmediadesign.com/test/arenareg/ctseastcoast2018/register.asp

 

 
Print this page
Send to a friend
   
spacer
Industry Events

Clinical Trial Supply Europe 2019

13-14 March 2019, Milan, Italy

Following on from our largest and most engaging meeting to date, Clinical Trial Supply Europe will be returning to Milan for its 20th year in 2019! The 19th annual edition welcomed pharmaceutical companies across Europe who got together to share knowledge and issues regarding clinical trial supplies, both with regards to operational and technological challenges. Over the two days, delegates discussed issues which affected their business in our dedicated operational and technological streams.
More info >>

Banner of DIA_Europe_Events_95 on Samedan Banner of Drug Delivery Partnership 2018_events_97 on Samedan

White Papers

R&D to Product: How to Reduce Costly Scale-Up Problems

Natoli Engineering Company, Inc.

When scaling a new drug formulation from the development side of R&D into manufacturing, there is often a reality check with respect to process scaleup and performance of the formulation at production levels. Problems with capping/lamination and sticking/ picking are often first realized when a formulation is introduced to a level of compression required to supply market demand.
More info >>


News and Press Releases

Clinical and Regulatory Operational Excellence Forum

1. Innovative technologies are expected to take clinical development, licensing, and other regulatory processes to the next level in the future. What do you see are the biggest challenges facing companies when trying to cope with continued data growth in a fast changing environment? Pharmaceutical companies are heavily regulated and introducing change needs proof of acceptance by the authorities. The chance that authorities do not agree with that change makes the industry risk averse. Changes in a stable GxP environment are almost by default seen as a risk, however, not adapting to new technologies should also be seen as a risk! Therefore, ICH developed the ICH Q8, Q9, Q10, Q11, and Q12 guidelines, to anticipate change and implement changes much faster, with less of a regulatory burden. Nevertheless, industry is not picking up with the desired pace. Why not?
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement